✦ Where quality meets affordability · Biomed-tested · Certified

Abbott, Dexcom grapple with diabetes coverage ahead of planned Medicare expansion

Abbott, Dexcom grapple with diabetes coverage ahead of planned Medicare expansion
Summary

Abbott said it is facing pricing pressure and slower growth ahead of a planned coverage expansion for people with Type 2 diabetes.

Competitor Dexcom, however, did not experience the same slowdown.

Read the full article ↗Looking to buy or rent? Get a quote

More from MedTech Dive

AdvaMed Chair Mick Farrell shares his top priorities, challenges for the medtech industryAbbott starts pivotal trial for mitral valve replacement deviceLabcorp, Quest urge RESULTS Act passage as lab payment cuts loomStryker lowers 2026 guidance after slowdown in hip, knee procedures